Skip to end of metadata
Go to start of metadata

You are viewing an old version of this content. View the current version.

Compare with Current View Version History

Version 1 Next »

Gene-disease assertions not curated here (add link or write note):

Disease

Congenital adrenal hyperplasia

Inheritance

Autosomal recessive

Prevalence

 

Source:

Rapid or full curation?

  • Rapid
  • Full

ClinGen / GenCC / BabySeq / HGMD / OMIM

ClinGen - Dosage score is 30 (Gene associated with AR phenotype) for CAH. GenCC - Myriad/LMM/Invitae - Definitive or Strong for CAH. BabySeq - definitive for CAH (PMIDs: 9556656, 9521938, 7629224, 9300201, 18000084, 18323673, 12915679). Given these curations, scoring for gene-disease validity is unnecessary.

Clinical Validity Scoring Notes and points

N/A

Clinical Validity Points Total

N/A

Clinical Validity Classification

 Classifications (pts)

Definitive (12pts)

Strong (12pts)

Moderate (7-11pts)

Limited (0.1-6pts)

No genetic evidence

Refuted

Disputed

Definitive (using babyseq citations below)

Source: PMID:9556656, 9521938, 7629224, 9300201, 18000084, 18323673, 12915679

Molecular Mechanism

 Mechanisms

Loss of function

Gain of function

Dominant negative

Unknown

Other

Loss of function

(based on ClinGen dosage score)

Penetrance

 options

Complete (100%)

High (≥80%)

Moderate  (<80% and >20%)

Low (≤20%)

(list source/PMID)

Source:

Age of Onset

 options

Congenital

Pediatric

Adolescent

Adulthood

Late adulthood

(list source/PMID)

Severity

 Options

Embryonic lethal - presence of a pathogenic variant or variants is not compatible with life. The penetrance must be complete.
Severe - presence of a pathogenic variant or variant(s) results in significantly reduced fitness. The penetrance must be complete or high.
Moderate - significant morbidity or mortality due to clinical features, but fitness may not be reduced, or penetrance is reduced.
Mild - Presence of a variant or variant(s) is not associated with reduced fitness, no significant morbidity or mortality, and/or penetrance is low.
None - presence of a variant results in no phenotype. An example is recessive disorders in which no phenotype is reported in carriers.

Severe to mild

Clinical Features

Classic:

  • Simple virilizing form - Virilization of external genitalia of genetic females. Excess adrenal androgen production. Those who do not receive glucocorticoid replacement therapy develop precocious development of pubic and axillary hair, acne, rapid linear growth, and advanced bone age. Untreated males have progressive penile enlargement and small testes. Untreated females have clitoral enlargement, hirsutism, male pattern baldness, menstrual abnormalities, and reduced fertility.

  • Salt wasting form - Virilization plus risk for life-threatening salt-wasting crises at birth. Features include poor feeding, weight loss, failure to thrive, vomiting, dehydration, hypotension, hyponatremia, and hyperkalemic metabolic acidosis progressing to adrenal crisis (azotemia, vascular collapse, shock, and death). Males are at particular risk because normal male genitalia at birth does not alert to the dx; females with ambiguous genitalia usually prompts early dx and treatment

  • CAUSED BY SEVERE VARIANTS ON BOTH ALLELES

Non-classic:

  • hyperandrogenism

  • females are not virilized at birth, postnatal symptoms may include hirsutism, frontal baldness, delayed menarche, menstrual irregularities, and infertility.

  • Males may have early beard growth and an enlarged phallus with relatively small testes.

  • CAUSED BY TWO MILD/NONCLASSIC VARIANTS OR 1 MILD + 1 SEVERE. Nonclassic variants include p.Pro31Leu, p.Val282Leu, p.Pro454Ser

Sources:

HPO Terms

https://hpo.jax.org/app/

Gene SOPs & Notes

  • A nonfunctional pseudogene, CYP21A1P is located ~30kb from the CYP21A2 genes. High sequence homology at ~98% between exons.

  • A common duplication haplotype consists of the Gln319Ter pathogenic variant co-existing with a duplication on the same chromosome. Individuals with this duplication are at risk of being diagnosed as a carrier when in fact they have two normal functioning alleles.

  • High structural variability at the locus caused by unequal crossing over, results in deletions, duplications, quadruplications and gene-pseudogene conversions.

    • Gene conversions can include CYP21A1P variants 33961029

  • CYP21A1P is transcribed but its mRNA cannot encode a functional protein owing to at least 10 deleterious mutations (143, 144) including 2 frameshifts (8 bp deletion in exon 3, 1 bp insertion in exon 7, a nonsense mutation (p.Gln318stop; Q318X) (150), and a mutation in intron 2 that activates a cryptic splice site and causes an extra 19 nucleotides to be included in the mRNA (151). Missense mutations in the pseudogene include p.Pro30Leu (P30L) (107), p.Ile172Asn (I172N) (152), a cluster of missense mutations in exon 6, p.Ile236Asn, Val237Glu, Met239Lys (I236N, V237E, M239K), p.Val281Leu (V281L) (153), and p.Arg356Trp (R356W).

  • Genotype-phenotype correlations

Curation Summary

 Examples

- The @GENE@ is associated with @inheritance pattern@ @condition@, which is characterized by @clinical features@ (PMIDs).

- Variable expression or severity:
The severity and expressivity of the disorder is highly variable, even within families.
- If multiple conditions associated with the gene:
It has also been associated with @inheritance pattern@ @condition@, which is characterized by @clinical features@ (PMIDs).

- Limited evidence gene: The PCNA gene has been reported in individuals with early onset autosomal recessive ataxia (PMID: 33426167, 24911150), however, evidence supporting this gene-dIsease relationship is limited

Case ID, Curator name, Date, Jira ticket link

  • No labels